期刊文献+

Arterial Ischemic Stroke as a First Manifestation of Trousseau’s Syndrome

Arterial Ischemic Stroke as a First Manifestation of Trousseau’s Syndrome
下载PDF
导出
摘要 Malignancy related hypercoagulobility can manifest as acute arterial infarction, non-bacterial thrombotic endocarditis and thrombophlebitis. Rarely, ischemic stroke may be first symptom for a systemic occult cancer. We presented 62-year-old man who had recurrent stroke as the initial manifestation of an occult neoplastic process. Subsequently, the patient had venous thrombotic disease that led to the diagnosis of the malignancy. Conclusions: Acute or sub-acute multiple ischemic stroke may be the first manifestation of in an occult cancer. Malignancy related hypercoagulobility can manifest as acute arterial infarction, non-bacterial thrombotic endocarditis and thrombophlebitis. Rarely, ischemic stroke may be first symptom for a systemic occult cancer. We presented 62-year-old man who had recurrent stroke as the initial manifestation of an occult neoplastic process. Subsequently, the patient had venous thrombotic disease that led to the diagnosis of the malignancy. Conclusions: Acute or sub-acute multiple ischemic stroke may be the first manifestation of in an occult cancer.
机构地区 不详
出处 《International Journal of Clinical Medicine》 2012年第1期43-45,共3页 临床医学国际期刊(英文)
关键词 MALIGNANCY Paraneoplestic STROKE OCCULT Cancer Hiperkoagulobility Ischemic STROKE Malignancy Paraneoplestic Stroke Occult Cancer Hiperkoagulobility Ischemic Stroke
  • 相关文献

参考文献1

二级参考文献15

  • 1Lee AY,Levine MN.Thrombophilic state induced by therapeutic agents in the cancer patient.Semin Thromb Hemost 1999; 25:137-145.
  • 2Goad KE,Gralnick HR.Coagulation disorders in cancer.Hematol Oncol Clin North Am 1996; 10:457-484.
  • 3Pinzon R,Drewinko B,Trujillo JM,Guinee V,Giacco G.Pancreatic carcinoma and Trousseau's syndrome:experience at a large cancer center.J Clin Oncol 1986; 4:509-514.
  • 4Perez-Lazaro C,Santos S,Morales-Rull JL,Garces-Redondo M,del Corral-Beamonte E,Fabre-Pi O,et al.Stroke as the first manifestation of a concealed pancreatic neoplasia.Rev Neurol 2004; 38:332-335.
  • 5Walsch-McMonagle D,Green D.Low-molecular-weight heparin in the management of Trousseau's syndrome.Cancer 1997; 80:649-655.
  • 6Rickles FR,Edwards RL.Activation of blood coagulation in cancer:Trousseau's syndrome revisited.Blood 1983; 62:14-31.
  • 7Graus F,Rogers LR,Posner JB.Cerebrovascular complications in patients with cancer.Medicine (Baltimore)1985; 64:16-35.
  • 8Minna JD,Bunn PA Jr.Pancreatic syndromes.In:De Vitra VT Jr.,Hellman S,Rosenberg SA,eds.Cancer:principles and practice of oncology.3rd ed.Philadelphia:JB Lippincott;1989:1920-1940.
  • 9Bick R.Coagulation abnormalities in malignancy:a review.Semin Thromb Hemost 1992; 18:353-372.
  • 10Sack GH Jr,Levin J,Bell WR.Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms:clinical,pathophysiologic,and therapeutic features.Medicine (Baltimore) 1977; 56:1-37.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部